TSS
BTTX

Two Sigma Securities’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

Two Sigma Securities’s Portfolio BTTX Stock Details BTTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,064
Closed -$19K – 3415
2022
Q3 		$19K Buy
+11,064
New +$20.2K ﹤0.01% 2307

Other funds holding BTTX

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Two Sigma Securities's BTTX Position: Q4 2022 in Review

Two Sigma Securities sold out of Better Therapeutics, Inc. Common Stock (BTTX) in Q4 2022, closing a stake of 11,064 shares — an estimated $19K sold.

Two Sigma Securities first reported a position in BTTX in Q3 2022 and held it in 1 quarter. The position peaked at $19K in Q3 2022. 17 funds tracked by Wall St. Rank hold BTTX as of Q4 2022.

  • Two Sigma Securities reported no remaining Better Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Securities sold 11,064 Better Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $19K.
  • Two Sigma Securities first reported a position in Better Therapeutics, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Two Sigma Securities's Better Therapeutics, Inc. Common Stock position peaked at $19K in Q3 2022.
  • 17 funds tracked by Wall St. Rank held Better Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Two Sigma Securities's 13F filing for Q4 2022, filed 14 Feb 2023.